within Pharmacolibrary.Drugs.ATC.P;

model P02CA03_1
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.15,
    Cl             = 0.42 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 400 / 1000000,
    adminCount     = 1,
    Vd             = 0.0008,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0028333333333333335,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Albendazole is an anthelmintic drug used to treat a broad range of parasitic worm infestations, including neurocysticercosis, hydatid disease, giardiasis, and soil-transmitted helminthiases. It disrupts the microtubule formation in parasites, leading to their immobilization and death. Albendazole is widely approved and used globally for these indications.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers after a single 400 mg oral dose, co-administered with a fatty meal.</p><h4>References</h4><ol><li><p>Nguyen, J, et al., &amp; Hoang, BX (2024). Oral Fenbendazole for Cancer Therapy in Humans and Animals. <i>Anticancer research</i> 44(9) 3725–3735. DOI:<a href=&quot;https://doi.org/10.21873/anticanres.17197&quot;>10.21873/anticanres.17197</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/39197912/&quot;>https://pubmed.ncbi.nlm.nih.gov/39197912</a></p></li><li><p>Ignacio, AL, et al., &amp; Laura, C (2023). Feeding Management and Albendazole Pharmacokinetics in Pigs. <i>Animals : an open access journal from MDPI</i> 13(3) –. DOI:<a href=&quot;https://doi.org/10.3390/ani13030474&quot;>10.3390/ani13030474</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/36766363/&quot;>https://pubmed.ncbi.nlm.nih.gov/36766363</a></p></li><li><p>Whittaker, C, et al., &amp; Boussinesq, M (2022). Factors associated with variation in single-dose albendazole pharmacokinetics: A systematic review and modelling analysis. <i>PLoS neglected tropical diseases</i> 16(10) e0010497–None. DOI:<a href=&quot;https://doi.org/10.1371/journal.pntd.0010497&quot;>10.1371/journal.pntd.0010497</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/36306320/&quot;>https://pubmed.ncbi.nlm.nih.gov/36306320</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end P02CA03_1;
